Historically, Safeguard Scientifics (NYSE:SFE) has provided capital and relevant expertise to fuel the growth of technology-driven businesses. Safeguard has a distinguished track record of fostering innovation and building market leaders that spans more than six decades. Currently, Safeguard is pursuing a focused strategy to value-maximize and monetize its ownership interests over a multiyear time frame to drive shareholder value.

Company profile
Ticker
SFE
Exchange
Website
CEO
Robert Rosenthal
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
SAFEGUARD SCIENTIFICS INC ET AL
SEC CIK
Corporate docs
Subsidiaries
Bonfield VII, Ltd. • Novitas Capital II Management, L.P. • Safeguard Capital Management, Inc. • Safeguard Delaware, Inc. • Safeguard Delaware II, Inc. • Safeguard Fund Management, Inc. • Safeguard PM SPV, Inc. • Safeguard Scientifics (Delaware), Inc. • Safeguard Technologies, Inc. • SFE Properties, Inc. ...
IRS number
231609753
SFE stock data
Latest filings (excl ownership)
8-K
Submission of Matters to a Vote of Security Holders
25 May 23
10-Q
2023 Q1
Quarterly report
5 May 23
8-K
Safeguard Scientifics Announces First Quarter 2023 Financial Results
4 May 23
DEFA14A
Additional proxy soliciting materials
6 Apr 23
DEF 14A
Definitive proxy
6 Apr 23
8-K
Other Events
13 Mar 23
10-K
2022 FY
Annual report
10 Mar 23
8-K
Safeguard Scientifics Announces Fourth Quarter and Year End 2022 Financial Results
9 Mar 23
8-K
Other Events
10 Jan 23
8-K
Departure of Directors or Certain Officers
4 Jan 23
Transcripts
SFE
Earnings call transcript
2022 Q4
9 Mar 23
SFE
Earnings call transcript
2022 Q3
3 Nov 22
SFE
Earnings call transcript
2022 Q2
12 Aug 22
SFE
Earnings call transcript
2022 Q1
8 May 22
SFE
Earnings call transcript
2021 Q4
10 Mar 22
SFE
Earnings call transcript
2021 Q3
7 Nov 21
SFE
Earnings call transcript
2021 Q2
13 Aug 21
SFE
Earnings call transcript
2021 Q1
9 May 21
SFE
Earnings call transcript
2020 Q4
4 Mar 21
SFE
Earnings call transcript
2020 Q3
7 Nov 20
Latest ownership filings
Financial summary
Quarter (USD) | Mar 23 | Dec 22 | Sep 22 | Jun 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 11.03 mm | 11.03 mm | 11.03 mm | 11.03 mm | 11.03 mm | 11.03 mm |
Cash burn (monthly) | 774.33 k | 699.92 k | 1.16 mm | 1.06 mm | 309.33 k | 265.42 k |
Cash used (since last report) | 1.72 mm | 1.55 mm | 2.58 mm | 2.35 mm | 687.23 k | 589.66 k |
Cash remaining | 9.31 mm | 9.48 mm | 8.45 mm | 8.69 mm | 10.35 mm | 10.44 mm |
Runway (months of cash) | 12.0 | 13.5 | 7.3 | 8.2 | 33.4 | 39.3 |
Institutional ownership, Q4 2022
54.4% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 41 |
Opened positions | 2 |
Closed positions | 6 |
Increased positions | 11 |
Reduced positions | 8 |
13F shares | Current |
---|---|
Total value | 21.69 bn |
Total shares | 8.88 mm |
Total puts | 0.00 |
Total calls | 1.50 k |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Contrarian Capital Management, L.L.C. | 1.20 mm | $3.72 bn |
Yakira Capital Management | 1.15 mm | $3.58 bn |
First Manhattan | 1.08 mm | $3.34 bn |
Almitas Capital | 796.63 k | $2.47 bn |
Horton Capital Partners | 707.85 k | $4.80 mm |
Vanguard | 692.92 k | $2.15 bn |
CM Management | 671.67 k | $2.08 mm |
Madison Avenue Partners | 463.38 k | $1.44 bn |
BLK Blackrock | 426.63 k | $1.32 bn |
Dimensional Fund Advisors | 348.95 k | $1.08 mm |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
15 May 23 | Salzman Eric | Common Stock | Payment of exercise | Dispose F | No | No | 1.76 | 5,297 | 9.32 k | 321,946 |
17 Apr 23 | Glass Russell D | common stock | Grant | Acquire A | No | No | 1.9 | 8,613 | 16.36 k | 97,394 |
17 Apr 23 | Beth Michelson | common stock | Grant | Acquire A | No | No | 1.9 | 7,178 | 13.64 k | 35,032 |
17 Apr 23 | Morrison Maureen F | common stock | Grant | Acquire A | No | No | 1.9 | 9,331 | 17.73 k | 100,615 |
17 Apr 23 | Ross D DeMont | Common Stock | Grant | Acquire A | No | No | 1.9 | 8,613 | 16.36 k | 198,250 |
News
12 Financials Stocks Moving In Friday's Intraday Session
2 Jun 23
Safeguard Scientifics Q1 EPS $(0.22) Up From $(0.40) YoY
4 May 23
Earnings Scheduled For May 4, 2023
4 May 23
Allbirds And 3 Other Stocks Under $2 Insiders Are Aggressively Buying
17 Mar 23
Safeguard Scientifics Q4 EPS $(0.30) Up From $(0.51) YoY
9 Mar 23
Press releases
Safeguard Scientifics Announces First Quarter 2023 Financial Results
4 May 23
SAFEGUARD SCIENTIFICS TO RELEASE FIRST QUARTER 2023 FINANCIAL RESULTS ON THURSDAY, MAY 4th
24 Apr 23
SAFEGUARD PROVIDES SUMMARY IMPACT ASSESSMENT FOLLOWING FDIC'S ACTIONS RELATING TO SILICON VALLEY BANK'S RECEIVERSHIP
13 Mar 23
TheracosBio Announces the Appointments of Jim Greenwood to Board of Directors and Jeff McGroarty as Chief Financial Officer
13 Mar 23
Safeguard Scientifics Announces Fourth Quarter and Year End 2022 Financial Results
9 Mar 23